▁Bre 8.0234375
ast 1.962890625
▁cancer 1.630859375
▁is 1.189453125
▁a 1.736328125
▁serious 3.26171875
▁health 2.205078125
▁concern 1.5087890625
▁affect 3.951171875
ing 0.00325775146484375
▁numerous 6.36328125
▁individuals 3.04296875
, 2.69140625
▁particularly 2.28515625
▁women 0.40185546875
, 1.93359375
▁around 2.732421875
▁the 0.002483367919921875
▁world 0.366455078125
. 0.1287841796875
▁It 2.521484375
▁is 0.42578125
▁cru 3.568359375
cial 0.0018291473388671875
▁to 0.322021484375
▁identify 4.421875
▁and 1.7724609375
▁understand 2.494140625
▁the 0.1436767578125
▁critical 7.1953125
▁factors 1.193359375
▁contrib 2.6640625
uting 0.00011098384857177734
▁to 0.014312744140625
▁its 2.78125
▁development 0.67138671875
▁in 1.578125
▁order 0.047027587890625
▁to 0.004100799560546875
▁develop 2.353515625
▁appropriate 4.015625
▁prevent 1.158203125
ion 0.66259765625
▁and 0.454833984375
▁treatment 0.15771484375
▁strateg 0.432373046875
ies 2.086162567138672e-05
. 0.05279541015625
▁Three 8.140625
▁major 2.283203125
▁factors 1.4521484375
▁influen 4.640625
cing 0.00030422210693359375
▁the 0.7265625
▁development 1.1533203125
▁of 0.133544921875
▁breast 0.034637451171875
▁cancer 0.004222869873046875
▁include 1.2548828125
▁her 4.1953125
ed 0.3173828125
ity 0.00029540061950683594
, 0.046112060546875
▁dise 11.140625
ases 0.042999267578125
▁of 3.04296875
▁the 0.11773681640625
▁m 5.1640625
amm 0.017822265625
ary 0.0035572052001953125
▁g 0.06610107421875
lands 0.58984375
, 0.104248046875
▁and 0.019317626953125
▁h 2.4453125
orm 0.0010232925415039062
onal 0.460693359375
▁factors 1.6767578125
. 0.106689453125
<0x0A> 0.78662109375
H 0.794921875
ered 0.01267242431640625
ity 0.0009822845458984375
▁plays 2.5
▁a 0.20263671875
▁significant 0.489501953125
▁role 0.00469970703125
▁in 0.01153564453125
▁breast 2.130859375
▁cancer 0.0015687942504882812
▁sus 4.16796875
cept 1.3709068298339844e-05
ibility 0.0002262592315673828
. 0.79052734375
▁In 4.109375
her 1.3447265625
ited 0.351318359375
▁gene 2.142578125
▁mut 0.167236328125
ations 0.005344390869140625
, 1.2275390625
▁such 0.405517578125
▁as 0.0003662109375
▁BR 0.51708984375
CA 0.0007910728454589844
1 0.062042236328125
▁and 0.11505126953125
▁BR 0.01024627685546875
CA 0.0004723072052001953
2 0.0032749176025390625
, 0.0859375
▁increase 1.654296875
▁the 0.348388671875
▁risk 0.0985107421875
▁of 0.017822265625
▁developing 0.250732421875
▁breast 0.3369140625
▁cancer 0.06475830078125
. 0.53125
▁Ind 3.458984375
ividual 0.0010042190551757812
s 0.0011587142944335938
▁with 0.2861328125
▁a 0.320068359375
▁strong 3.392578125
▁family 0.0178070068359375
▁history 0.002338409423828125
▁of 0.040740966796875
▁the 2.3046875
▁disease 0.06414794921875
▁are 0.410400390625
▁more 1.3359375
▁likely 0.101318359375
▁to 0.002460479736328125
▁inherit 2.15625
▁these 0.283203125
▁mut 0.465576171875
ated 3.66796875
▁gen 0.00360870361328125
es 0.0002446174621582031
. 0.9541015625
▁However 2.728515625
, 0.00019216537475585938
▁it 1.3876953125
▁is 0.1395263671875
▁important 0.438720703125
▁to 0.0003809928894042969
▁note 0.0261383056640625
▁that 0.00028634071350097656
▁her 2.177734375
edit 2.9609375
ary 0.00025916099548339844
▁factors 0.288330078125
▁account 2.09375
▁for 0.007328033447265625
▁only 0.1627197265625
▁a 0.6279296875
▁small 0.08673095703125
▁percentage 0.30908203125
▁of 0.0220947265625
▁breast 0.2744140625
▁cancer 0.031951904296875
▁cases 0.0261383056640625
, 1.5185546875
▁with 1.0146484375
▁the 1.5361328125
▁majority 0.22998046875
▁being 1.1552734375
▁sp 2.46484375
or 0.004695892333984375
adic 0.00152587890625
. 0.90380859375
<0x0A> 0.050628662109375
D 0.79345703125
ise 0.00206756591796875
ases 0.00579833984375
▁of 0.0338134765625
▁the 0.003662109375
▁m 0.1630859375
amm 0.00010180473327636719
ary 0.00038933753967285156
▁g 0.001087188720703125
lands 0.042388916015625
, 0.457763671875
▁such 0.19287109375
▁as 4.363059997558594e-05
▁ben 2.177734375
ign 6.079673767089844e-06
▁breast 0.415771484375
▁conditions 1.58203125
▁like 2.962890625
▁at 4.08984375
yp 0.016876220703125
ical 0.061279296875
▁hyper 0.37158203125
pl 0.0001647472381591797
asia 0.00569915771484375
▁or 2.70703125
▁lo 1.5107421875
b 0.0017261505126953125
ular 0.0029964447021484375
▁car 0.053131103515625
cin 6.783008575439453e-05
oma 0.001735687255859375
▁in 0.062744140625
▁situ 0.005802154541015625
, 0.55615234375
▁also 2.4375
▁contribute 1.3515625
▁to 0.01021575927734375
▁the 0.55419921875
▁development 0.2108154296875
▁of 0.0017805099487304688
▁breast 0.009307861328125
▁cancer 0.000423431396484375
. 0.00951385498046875
▁These 0.360107421875
▁conditions 0.23193359375
▁can 1.0556640625
▁sometimes 6.2265625
▁progress 0.5380859375
▁to 0.0631103515625
▁invas 0.740234375
ive 1.8596649169921875e-05
▁breast 1.4873046875
▁cancer 0.00794219970703125
▁if 0.7783203125
▁left 0.261962890625
▁un 0.00832366943359375
tre 0.0193939208984375
ated 2.300739288330078e-05
. 0.093017578125
▁Additionally 2.302734375
, 0.00013840198516845703
▁other 3.8984375
▁risk 3.833984375
▁factors 0.00030994415283203125
▁like 2.751953125
▁previous 4.35546875
▁radiation 1.3056640625
▁ther 0.71435546875
apy 0.0010499954223632812
▁or 1.6044921875
▁certain 2.80859375
▁h 2.9609375
orm 0.0008106231689453125
one 0.76953125
▁ther 0.544921875
ap 0.26611328125
ies 3.5643577575683594e-05
▁can 0.61474609375
▁increase 0.287109375
▁the 0.08758544921875
▁lik 3.013671875
elihood 0.0002357959747314453
▁of 0.00128936767578125
▁m 5.984375
align 0.88134765625
ant 0.398193359375
▁transformation 0.31396484375
▁in 2.3046875
▁the 1.712890625
▁m 0.86279296875
amm 0.0007767677307128906
ary 0.0002295970916748047
▁g 0.09381103515625
lands 0.2132568359375
. 0.049957275390625
<0x0A> 0.032073974609375
H 0.39990234375
orm 0.0005931854248046875
onal 0.050262451171875
▁factors 0.01540374755859375
▁are 1.64453125
▁another 1.2509765625
▁critical 1.6171875
▁contrib 2.103515625
utor 0.08489990234375
▁to 0.008941650390625
▁breast 0.421142578125
▁cancer 0.0006246566772460938
. 1.5361328125
▁Est 0.8212890625
ro 0.0204620361328125
gen 3.218650817871094e-05
▁expos 4.390625
ure 0.00052642822265625
▁over 5.4921875
▁a 0.84423828125
▁long 0.6708984375
▁period 0.04888916015625
▁of 0.5791015625
▁time 0.0006961822509765625
, 1.974609375
▁either 2.251953125
▁through 0.435302734375
▁early 5.43359375
▁on 2.232421875
set 4.8041343688964844e-05
▁of 0.17529296875
▁men 0.5625
stru 0.2177734375
ation 0.044647216796875
, 1.0458984375
▁late 0.341064453125
▁men 0.2076416015625
op 0.0013418197631835938
ause 0.001216888427734375
, 0.09613037109375
▁or 0.272216796875
▁h 2.79296875
orm 0.00010371208190917969
one 0.11700439453125
▁replacement 0.309814453125
▁ther 0.0019235610961914062
apy 0.0288543701171875
, 0.1895751953125
▁can 0.438720703125
▁increase 0.213134765625
▁the 0.0712890625
▁risk 0.02056884765625
▁of 0.0189208984375
▁breast 1.1845703125
▁cancer 0.002132415771484375
. 0.18017578125
▁High 3.0234375
▁levels 0.78515625
▁of 0.0002791881561279297
▁est 0.7392578125
ro 0.01511383056640625
gen 9.5367431640625e-06
▁can 0.80810546875
▁promote 1.5654296875
▁the 0.1844482421875
▁growth 0.144775390625
▁of 0.1451416015625
▁breast 0.4453125
▁cells 2.158203125
▁and 1.7373046875
▁potentially 5.203125
▁lead 0.1600341796875
▁to 0.0002579689025878906
▁the 1.4453125
▁development 0.114013671875
▁of 0.0003731250762939453
▁cancer 0.6865234375
ous 1.744140625
▁cells 2.779296875
. 0.0160675048828125
<0x0A> 0.43505859375
Det 7.8515625
ect 0.8076171875
ing 0.006961822509765625
▁early 2.8828125
▁met 10.0625
ast 0.179931640625
asis 0.8232421875
▁is 2.1953125
▁vital 3.671875
▁for 1.115234375
▁effective 1.431640625
▁breast 0.8681640625
▁cancer 0.0010690689086914062
▁treatment 0.16650390625
. 0.361328125
▁Met 2.509765625
ast 0.0035247802734375
asis 0.1146240234375
▁occurs 1.7705078125
▁when 0.0095062255859375
▁cancer 0.110107421875
▁cells 0.33837890625
▁spread 0.1702880859375
▁to 0.91796875
▁other 0.1282958984375
▁parts 0.330810546875
▁of 0.00045561790466308594
▁the 0.0004112720489501953
▁body 0.00018668174743652344
, 0.244384765625
▁making 1.0849609375
▁treatment 3.283203125
▁more 0.289306640625
▁challeng 0.72607421875
ing 4.863739013671875e-05
. 0.6767578125
▁Early 1.0322265625
▁detection 0.1976318359375
▁of 1.0322265625
▁met 0.153564453125
ast 9.906291961669922e-05
asis 0.0533447265625
▁enables 4.00390625
▁health 2.232421875
care 0.07452392578125
▁profession 0.84814453125
als 3.0994415283203125e-06
▁to 0.00316619873046875
▁plan 5.55859375
▁appropriate 1.673828125
▁inter 2.431640625
vent 0.07440185546875
ions 0.00336456298828125
▁and 1.29296875
▁strateg 6.9921875
ies 0.00882720947265625
▁to 0.7265625
▁reduce 2.720703125
▁its 3.70703125
▁impact 1.3115234375
▁on 0.68310546875
▁overall 4.25
▁outcome 6.57421875
▁and 2.4609375
▁surv 1.37109375
ival 0.0218963623046875
▁rates 1.2509765625
. 0.034454345703125
<0x0A> 0.2314453125
To 3.6171875
▁determine 3.966796875
▁the 1.056640625
▁ag 8.7421875
gress 0.01397705078125
iveness 0.054412841796875
▁of 0.12030029296875
▁breast 0.8701171875
▁cancer 0.0120849609375
, 0.324462890625
▁health 1.935546875
care 0.0216064453125
▁profession 0.2012939453125
als 3.337860107421875e-06
▁employ 3.697265625
▁various 1.4755859375
▁methods 1.759765625
. 1.3564453125
▁These 1.6044921875
▁include 0.9248046875
▁tum 2.951171875
or 0.0662841796875
▁size 1.36328125
▁and 1.8486328125
▁stage 2.5546875
, 0.1903076171875
▁grade 3.67578125
▁( 4.609375
d 5.51171875
iffer 0.2037353515625
enti 0.016082763671875
ation 0.09979248046875
▁of 1.6240234375
▁cancer 0.69580078125
▁cells 0.322265625
), 0.11968994140625
▁l 1.7548828125
ym 0.000377655029296875
ph 0.00015723705291748047
▁node 0.07916259765625
▁invol 0.32568359375
vement 0.00016427040100097656
, 0.0418701171875
▁and 0.396484375
▁the 2.34375
▁presence 0.40673828125
▁of 0.0748291015625
▁specific 2.3828125
▁bi 1.796875
om 0.0229644775390625
ark 0.0012521743774414062
ers 0.004856109619140625
▁like 2.8125
▁human 2.447265625
▁e 0.00780487060546875
pid 0.0008306503295898438
erm 0.00252532958984375
al 0.00042510032653808594
▁growth 0.002651214599609375
▁factor 0.00289154052734375
▁re 0.07135009765625
ceptor 0.035797119140625
▁ 0.15966796875
2 0.00015473365783691406
▁( 0.062225341796875
HER 0.0038433074951171875
2 0.07733154296875
) 1.3671875
▁or 1.197265625
▁h 3.375
orm 0.0040283203125
one 0.024932861328125
▁re 0.01229095458984375
cept 0.46826171875
ors 0.0006709098815917969
▁( 1.7255859375
estro 0.493896484375
gen 9.894371032714844e-06
▁or 2.9765625
▁pro 0.0007214546203613281
g 0.0010442733764648438
ester 1.5735626220703125e-05
one 0.0007681846618652344
). 0.303955078125
▁These 1.8564453125
▁factors 0.71630859375
▁help 1.771484375
▁to 1.6650390625
▁determine 0.984375
▁treatment 4.33984375
▁options 0.421875
, 1.689453125
▁such 1.228515625
▁as 0.00010919570922851562
▁surg 0.48974609375
ery 0.047210693359375
, 0.09771728515625
▁chem 0.452392578125
other 0.0010309219360351562
apy 2.7894973754882812e-05
, 0.0211334228515625
▁radiation 1.466796875
▁ther 0.221435546875
apy 0.0001016855239868164
, 0.02337646484375
▁or 0.51416015625
▁target 1.2529296875
ed 0.0023555755615234375
▁ther 0.02410888671875
ap 1.61328125
ies 8.928775787353516e-05
. 0.398193359375
<0x0A> 0.09564208984375
In 2.11328125
▁conclusion 0.67529296875
, 0.0004088878631591797
▁understanding 1.9462890625
▁the 0.160888671875
▁critical 1.0
▁factors 0.036712646484375
▁contrib 0.430419921875
uting 8.344650268554688e-06
▁to 0.0003085136413574219
▁breast 0.50830078125
▁cancer 0.0002777576446533203
▁development 0.426513671875
, 2.478515625
▁such 1.0087890625
▁as 0.00019693374633789062
▁her 0.05438232421875
ed 0.0423583984375
ity 1.5854835510253906e-05
, 0.0052337646484375
▁dise 0.45458984375
ases 0.00030803680419921875
▁of 0.00318145751953125
▁the 0.0118865966796875
▁m 0.001132965087890625
amm 9.894371032714844e-06
ary 8.320808410644531e-05
▁g 0.0004024505615234375
lands 0.00716400146484375
, 0.00853729248046875
▁and 0.03515625
▁h 0.0011339187622070312
orm 1.1920928955078125e-06
onal 0.00665283203125
▁factors 0.005771636962890625
, 0.0273590087890625
▁is 0.1868896484375
▁cru 0.71630859375
cial 1.1324882507324219e-05
▁in 2.236328125
▁prevent 2.69140625
ing 0.464111328125
▁its 4.29296875
▁occurrence 0.9267578125
▁and 0.47509765625
▁impro 1.6796875
ving 0.00016486644744873047
▁treatment 0.78662109375
▁out 0.084228515625
comes 2.0384788513183594e-05
. 0.03570556640625
▁Early 0.494140625
▁detection 0.098388671875
▁of 0.1533203125
▁met 0.016754150390625
ast 4.5418739318847656e-05
asis 0.00860595703125
▁is 0.98291015625
▁essential 1.3818359375
▁for 0.5400390625
▁effective 0.2479248046875
▁treatment 0.548828125
▁planning 2.919921875
, 1.14453125
▁while 3.841796875
▁determ 2.083984375
ining 0.0150909423828125
▁the 0.2391357421875
▁ag 0.015106201171875
gress 0.0002751350402832031
iveness 0.001922607421875
▁of 0.005504608154296875
▁breast 0.3349609375
▁cancer 0.0006122589111328125
▁a 5.1796875
ids 0.00852203369140625
▁in 0.14306640625
▁choosing 2.21875
▁appropriate 0.398681640625
▁treatment 0.79833984375
▁strateg 2.072265625
ies 2.384185791015625e-06
. 0.047393798828125
▁Health 2.267578125
▁aw 9.75
aren 7.033348083496094e-06
ess 1.4781951904296875e-05
▁campaign 3.3515625
s 0.00048732757568359375
, 1.291015625
▁gen 2.6328125
etic 0.0017957687377929688
▁testing 0.46337890625
, 0.06243896484375
▁and 0.162841796875
▁regular 0.732421875
▁screen 0.80712890625
ings 1.24609375
▁are 0.9384765625
▁essential 1.5556640625
▁in 0.9365234375
▁address 3.92578125
ing 6.99758529663086e-05
▁breast 1.8896484375
▁cancer 0.0007605552673339844
▁and 1.3212890625
▁reducing 1.5830078125
▁its 0.08148193359375
▁impact 0.454833984375
▁on 0.061248779296875
▁individuals 0.49853515625
▁and 0.360595703125
▁communities 0.68310546875
. 0.381591796875
